Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CAMP4 Therapeutics Corporation - Common Stock
(NQ:
CAMP
)
2.930
-0.180 (-5.79%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
86,265
Open
2.960
Bid (Size)
2.800 (2)
Ask (Size)
3.100 (4)
Prev. Close
3.110
Today's Range
2.860 - 3.100
52wk Range
1.305 - 12.26
Shares Outstanding
20,161,073
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Healthcare Companies Insiders Are Buying
October 14, 2025
Insiders are buying these three healthcare companies that have catalysts to drive their share prices higher in the upcoming years.
Via
MarketBeat
Topics
Initial Public Offering
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
October 01, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
Performance
YTD
-40.6%
-40.6%
1 Month
+5.8%
+5.8%
3 Month
+76.5%
+76.5%
6 Month
+48.0%
+48.0%
1 Year
-73.2%
-73.2%
More News
Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 10, 2025
Via
Benzinga
Wednesday's after hours session: top gainers and losers
September 10, 2025
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 10, 2025
Via
Benzinga
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
September 10, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
Camp4 Reports Q2 Revenue Beats Estimates
August 14, 2025
Via
The Motley Fool
CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
August 14, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 28, 2025
Via
Benzinga
Sequans Appoints Jason W. Cohenour to Board of Directors
June 30, 2025
Via
Newsfile
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 11, 2025
Via
Benzinga
This Sandisk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
May 27, 2025
Via
Benzinga
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American
May 16, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
May 13, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 06, 2025
Via
Benzinga
Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
May 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 02, 2025
Via
Benzinga
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
April 28, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2
April 10, 2025
Via
Benzinga
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
March 27, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
March 18, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 18, 2025
Via
Benzinga
CAMP4 to Participate in Upcoming Investor Conferences
February 06, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
Frequently Asked Questions
Is CAMP4 Therapeutics Corporation - Common Stock publicly traded?
Yes, CAMP4 Therapeutics Corporation - Common Stock is publicly traded.
What exchange does CAMP4 Therapeutics Corporation - Common Stock trade on?
CAMP4 Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CAMP4 Therapeutics Corporation - Common Stock?
The ticker symbol for CAMP4 Therapeutics Corporation - Common Stock is CAMP on the Nasdaq Stock Market
What is the current price of CAMP4 Therapeutics Corporation - Common Stock?
The current price of CAMP4 Therapeutics Corporation - Common Stock is 2.930
When was CAMP4 Therapeutics Corporation - Common Stock last traded?
The last trade of CAMP4 Therapeutics Corporation - Common Stock was at 10/17/25 04:00 PM ET
What is the market capitalization of CAMP4 Therapeutics Corporation - Common Stock?
The market capitalization of CAMP4 Therapeutics Corporation - Common Stock is 59.07M
How many shares of CAMP4 Therapeutics Corporation - Common Stock are outstanding?
CAMP4 Therapeutics Corporation - Common Stock has 59M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.